Hong Kong: Manulife launches industry-leading 'cancer drug support service' with collaborators

| 24 Mar 2025

The service is launched in collaboration with Prosper Health, a leading health insurance service provider in mainland China and Shenzhen New Frontier United Family Hospital (the Hospital).

Through this collaboration, Manulife has become the first insurer in Hong Kong to offer this service to eligible customers with selected critical illness plans.

Additionally, this service will be available to eligible customers with specific medical plans. The new service aims to offer customers an option to access cost-effective cancer medications available in mainland China. 

This collaboration highlights Manulife’s commitment to enhancing its health and protection offerings in response to the growing demand for medical services in mainland China among Hong Kong residents.

It also reinforces Manulife’s dedication to empowering customers on their journey toward healthier and more fulfilling lives, with this pioneering service serving as an example of that mission.

Through this new service, eligible Manulife customers with cancer medications prescribed by their specialists can connect with Manulife’s Personalized Medical Case Managers for assistance. These Medical Case Managers, who are qualified nurses with extensive healthcare experience, will help customers verify with Prosper Health the availability and price of their prescribed cancer medications at the Hospital and, once confirmed, coordinate with Prosper Health to schedule an initial consultation with the Hospital’s specialists upon request.

Additionally, eligible customers are entitled to a complimentary door-to-door limousine service for convenience throughout the campaign period.

“We are thrilled to partner with Prosper Health and Shenzhen New Frontier United Family Hospital to elevate our customers’ health journey through the launch of our Cancer Drug Support Service,” said Ms Carrie Tong, Chief Operations Officer of Manulife Hong Kong and Macau.

“This innovative service is designed to provide our customers with a cost-effective option to access prescribed cancer medications in mainland China. By offering this alternative, we aim to help alleviate the financial burden often associated with critical illness care, enabling our customers to reduce their cancer medication expenses and focus on long-term financial planning. This initiative not only supports their physical well-being but also provides essential peace of mind during what can be an incredibly challenging time.”

Mr Thom Gao, Co-founder and Chief Operations Officer of Prosper Health, said, “This collaboration complements our existing cross-border medical services, providing more holistic medical support for customers with specific needs. We hope to bring high-quality, affordable medical services to more patients.”

Mr Brian Siu, Executive Director and Chief Operations Officer of New Frontier GBA, Shenzhen New Frontier United Family Hospital, said, “Through significantly simplifying the medical process for patients and ensuring they can focus on their treatment with peace of mind, we believe this collaboration is not only an innovation in medical service models but also a profound response to patients' health needs, bringing hope and peace of mind to more families.”